[Potential of adrenomedullin as a therapeutic tool for left ventricular remodeling after myocardial infarction].
Nakamura
Ryosai
R
First Department of Internal Medicine, Miyazaki Medical College, University of Miyazaki.
Kato
Johji
J
Kitamura
Kazuo
K
Imamura
Takuroh
T
Eto
Tanenao
T
D053607:Adrenomedullin; D000818:Animals; D002455:Cell Division / Q000187:drug effects; D015316:Genetic Therapy; D006801:Humans; D009203:Myocardial Infarction / Q000503:physiopathology / Q000628:therapy*; D015428:Myocardial Reperfusion Injury / Q000628:therapy; D032383:Myocytes, Cardiac / Q000166:cytology; D009318:Natriuresis / Q000187:drug effects; D018384:Oxidative Stress / Q000187:drug effects; D010455:Peptides / Q000235:genetics / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use*; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects; D020257:Ventricular Remodeling / Q000187:drug effects
D010455:Peptides; D011518:Proto-Oncogene Proteins; D011994:Recombinant Proteins; D053607:Adrenomedullin; D017346:Protein Serine-Threonine Kinases; D051057:Proto-Oncogene Proteins c-akt